Daxor (FRA:DX5) Other Liabilities for Banks : €0.07 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Daxor Other Liabilities for Banks?

Daxor's quarterly other liabilities (bank) increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.00 Mil) and increased from Dec. 2023 (€0.00 Mil) to Jun. 2024 (€0.07 Mil).

Daxor's annual other liabilities (bank) declined from Dec. 2021 (€0.64 Mil) to Dec. 2022 (€0.00 Mil) but then stayed the same from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.00 Mil).

Daxor Other Liabilities for Banks Historical Data

The historical data trend for Daxor's Other Liabilities for Banks can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daxor Other Liabilities for Banks Chart

Daxor Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Liabilities for Banks

Get a 7-Day Free Trial

0.01

0.52

0.64

Daxor Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Liabilities for Banks	Get a 7-Day Free Trial															-	-	-	-	0.07

Daxor Other Liabilities for Banks Calculation

As used by the bank, this category may include numerous accounts not included under other specific liability categories. In some banks, individual accounts are established for control purposes and appear as other liabilities on the balance sheet.

Daxor Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daxor Corp (FRA:DX5) » Definitions » Other Liabilities for Banks

Comparable Companies

Traded in Other Exchanges

DXR:USA

Address

109 Meco Lane, Oak Ridge, TN, USA, 37830

Website

https://www.daxor.com

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Daxor Headlines

No Headlines